Proven
TB-500 (Thymosin Beta-4 Fragment)
The prediction game
Call it: rising or fading?
Where does TB-500 (Thymosin Beta-4 Fragment) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 7.5/10
TB-500 (Thymosin Beta-4 Fragment) is a 7.9 / 10 fit for people considering recovery repair, injury recovery, wound healing, eye vision, with the strongest case in the populations already represented by the evidence rather than broad wellness use. [Sosne 2023](https://pubmed.ncbi.nlm.nih.gov/36613994/) and [Sosne 2015](https://pubmed.ncbi.nlm.nih.gov/26056426/) give the report its main anchors, while the score stays worth trying because benefits are context-dependent and the evidence still leaves responder, dose, and long-term questions open. TB-500 (Thymosin Beta-4 Fragment) makes the most sense when the target is concrete, such as a lab marker, symptom pattern, training limitation, or recovery bottleneck. It makes less sense as a background habit taken on faith. In practice, treat TB-500 (Thymosin Beta-4 Fragment) as a tracked experiment: define the outcome first, watch for tradeoffs, and let the response decide whether it earns a place. ✅ Best for: Active adults with acute, well-defined tendon, ligament, muscle, or post-surgical recovery needs who already understand injectable peptide tradeoffs. TB-500 is most rational when conservative recovery is underway but too slow, when BPC-157 alone feels too narrow, and when the user can verify peptide quality. It is also worth tracking for people interested in full-length ophthalmic Tbeta4 research, where human evidence is much stronger than the musculoskeletal TB-500 story. Pair it with progressive loading, protein, sleep, and clinician-aware recovery planning. ❌ Avoid if: You have active cancer, recent cancer, a strong family pattern of aggressive cancers, pregnancy, breastfeeding, or a WADA-tested sport context. Avoid TB-500 if you cannot verify source quality or sterile handling, because gray-market injection risk is separate from the molecule's theoretical profile. Avoid it if you need guideline-grade evidence before acting, because no large human musculoskeletal RCT exists. Also avoid using TB-500 to push through pain while ignoring diagnosis, imaging, surgical instructions, load management, or infection signs.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
In the news this week: BrainFlow, Jay Campbell.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Proven
- Trend
- Begins with Edition 2
- Momentum
- 0.0%
- BioHarmony Score
- 7.5/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.